Clinical Trial Supplies Market Intelligence Report - Global Forecast to 2027

Clinical Trial Supplies Market Intelligence Report - Global Forecast to 2027

The Global Clinical Trial Supplies Market is projected to reach USD 32,742.34 million by 2027 from USD 20,984.94 million in 2021, at a CAGR 7.69% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Clinical Trial Supplies Market size was estimated at USD 8,238.68 million in 2021 and expected to reach USD 8,860.65 million in 2022, at a CAGR 7.65% to reach USD 12,825.63 million by 2027.
• The Asia-Pacific Clinical Trial Supplies Market size was estimated at USD 4,691.18 million in 2021 and expected to reach USD 5,094.62 million in 2022, at a CAGR 7.99% to reach USD 7,443.63 million by 2027.
• The Europe, Middle East & Africa Clinical Trial Supplies Market size was estimated at USD 8,055.07 million in 2021 and expected to reach USD 8,639.78 million in 2022, at a CAGR 7.55% to reach USD 12,473.06 million by 2027.

Market Segmentation & Coverage:

The report on clinical trial supplies identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the clinical trial supplies to forecast the revenues and analyze the trends in each of the following sub-markets:

Services:

• Comparator Sourcing
• Logistics & Distribution
  • Cold Chain Distribution
  • Non-Cold Chain Distribution
• Manufacturing
• Packaging, Labeling, & Blinding
• Storage & Retention

Type:

• Biologic Drugs
• Medical Devices
• Small Molecules

Phase:

• BA/ BE studies
• Phase 1
• Phase 2
• Phase 3
• Phase 4

Therapeutic Area:

• Blood Disorders
• Cardiovascular Diseases
• CNS & Mental Disorders
• Dermatological Disorders
• Digestive Disorders
• ENT Diseases
• Immunology
• Infectious Diseases
• Metabolic Disorders
• Nephrology
• Oncology
• Rare Diseases
• Respiratory Disorders

End User:

• Contract Research Organisations (CROs)
• Medical Devices Companies
• Pharmaceutical & Biotechnology companies

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • Arizona
    • California
    • Florida
    • Illinois
    • New York
    • North Carolina
    • Ohio
    • Oregon
    • Pennsylvania
    • Tennessee
    • Texas
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• Almac Group
• Ancillare, LP
• Biocair International Limited
• Catalent, Inc.
• Clinigen Group PLC
• Eurofins Scientific Group
• ICON PLC
• Infosys Limited
• KLIFO A/S
• Liveo Research GmbH
• Lonza Group AG
• Marken Limited
• Myonex, Inc.
• N-SIDE SA
• Parexel International Corporation
• PCI Pharma Services
• Piramal Pharma Solutions
• SIRO Clinpharm Private Limited
• Thermo Fisher Scientific, Inc.
• UDG Healthcare PLC
• Walden

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 20,984.94 million

Estimated Year Value: USD 22,595.06 million

Forecast Year Value: USD 32,742.34 million

CAGR (%): 7.69%.

Please Note: PDF & Excel + Online Access - 1 Year